journal
https://read.qxmd.com/read/38078601/salt-restriction-for-treatment-of-hypertension-current-state-and-future-directions
#41
REVIEW
Philip Nolan, John W McEvoy
PURPOSE OF REVIEW: Given the adverse effects of excess dietary sodium chloride (also known as table salt) on blood pressure (BP) and cardiovascular disease (CVD), restriction of dietary sodium is recommended by numerous guidelines. The strictest of these recommend no more than 1.5 g/day of dietary sodium among hypertensive persons. However, average dietary sodium intake in the population is closer to 5 g/day and there is debate about whether too much sodium restriction may be associated with increased CVD risk...
January 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38078600/measuring-lipoprotein-a-for-cardiovascular-disease-prevention-in-whom-and-when
#42
REVIEW
Peter E Thomas, Signe Vedel-Krogh, Børge G Nordestgaard
PURPOSE OF REVIEW: The aim of this study is to summarize major cardiovascular guideline recommendations on lipoprotein(a) and highlighting recent findings that emphasize how measuring lipoprotein(a) once in all adults is meaningful regardless of age, sex, comorbidities, or ethnicity. RECENT FINDINGS: Many international guidelines now recommend once in a lifetime measurement of lipoprotein(a) in all adult individuals to facilitate accurate risk prediction. Lipoprotein(a)-lowering therapy to reduce cardiovascular disease is on the horizon, with results from the first phase 3 trial expected in 2025...
January 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/37934715/2023-update-on-equity-diversity-and-inclusion-in-canadian-cardiac-surgery
#43
REVIEW
Lina A Elfaki, Rosalind Groenewoud, Akachukwu Nwakoby, Areeba Zubair, Raj Verma, Bobby Yanagawa
PURPOSE OF REVIEW: Despite efforts to diversify the medical field, cardiac surgery remains amongst the least diverse specialties. Specifically, the percentage of women and racial minorities has remained low in past few decades. This may impact prospective trainee recruitment and surgical care. This paper highlights recent efforts that aim to promote diversity and inclusion of the Canadian cardiac surgical workforce. RECENT FINDINGS: Formal programs have been established to support students at different stages of training...
January 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/37921758/cardiovascular-disease-prevention-in-women-the-current-state-in-2023
#44
REVIEW
Aarti Purohit, Yoo Jin Kim, Erin D Michos
PURPOSE OF REVIEW: Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality for women globally. The purpose of this review is to provide an updated overview of CVD prevention in women, focusing on what is currently understood about female-specific or female-predominant CVD risk factors and the importance of tailored strategies for risk assessment and medical interventions. RECENT FINDINGS: Recent studies have demonstrated the need to account for risk factors specific to women in current risk assessment models for CVD, including early menarche, polycystic ovary syndrome, adverse pregnancy outcomes, early menopause, and chronic inflammatory conditions...
January 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/37751365/advances-in-cardiac-pacing-with-leadless-pacemakers-and-conduction-system-pacing
#45
REVIEW
Sulaiman Somani, Albert J Rogers
PURPOSE OF REVIEW: The field of cardiac pacing has undergone significant evolution with the introduction and adoption of conduction system pacing (CSP) and leadless pacemakers (LLPMs). These innovations provide benefits over conventional pacing methods including avoiding lead related complications and achieving more physiological cardiac activation. This review critically assesses the latest advancements in CSP and LLPMs, including their benefits, challenges, and potential for future growth...
January 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/37712587/perspectives-on-pulsed-field-ablation-how-to-judge-endpoints
#46
REVIEW
Valeria Anglesio, Atul Verma
PURPOSE OF REVIEW: This review highlights pulse field ablation's (PFA) significance in treating atrial fibrillation. PFA uses short-pulsed electrical fields, offering safety advantages over thermal methods. Multicenter studies' findings on PFA's safety, efficiency, and efficacy, compared with thermal techniques, are discussed. RECENT FINDINGS: The review encompasses major PFA systems utilized in multicenter studies: penta-spline, circular, and lattice catheters...
January 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38116804/wellness-and-burnout-in-cardiac-surgery-not-black-and-white
#47
JOURNAL ARTICLE
Aliya Izumi, Akachukwu Nwakoby, Raj Verma, Bobby Yanagawa
PURPOSE OF REVIEW: Despite a growing emphasis on burnout in medicine, there remains a paucity of data in cardiac surgery. Herein, we summarize recent data on cardiac surgeon well being and identify factors for consideration in future burnout inquiries and management. RECENT FINDINGS: Overall, 70-90% of cardiothoracic surgeons report job satisfaction in the United States. However, 35-60% still endorse burnout symptoms, and the specialty reports some of the highest rates of depression (35-40%) and suicidal ideation (7%)...
December 21, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/38116802/a-comprehensive-overview-of-surgical-and-transcatheter-therapies-to-treat-tricuspid-regurgitation-in-patients-with-heart-failure
#48
JOURNAL ARTICLE
Vincent Chen, Omar Abdul-Jawad Altisent, Rishi Puri
PURPOSE OF REVIEW: The unique pathophysiologic considerations of severe tricuspid regurgitation (TR) have led to advancements in surgical and transcatheter treatments. The purpose of this review is to highlight the current surgical and transcatheter tricuspid valve interventions (TTVI) to functional TR. RECENT FINDINGS: Surgical repair with ring annuloplasty consistently demonstrates better outcomes than surgical replacement or other repair approaches. However, surgical uptake of TR correction remains relatively low, and operative mortality rates are still high owing to multiple comorbidities and advanced tricuspid valve disease/right ventricular dysfunction at time of referral...
December 19, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/38116785/worsening-heart-failure-a-concept-in-evolution
#49
JOURNAL ARTICLE
Max Puthenpura, Jennifer Wilcox, W H Wilson Tang
PURPOSE OF REVIEW: Worsening heart failure (WHF) has developed as a unique definition within heart failure (HF) in recent years. It captures the disease as a dynamic process. This review describes what is currently known about WHF, why it should be considered a discrete scientific endpoint, and future directions for research. RECENT FINDINGS: There is no single agreed upon definition for WHF. It can be identified as being due to treatment side-effects, related to concomitant comorbidity, or true disease progression...
December 19, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/38116820/considerations-challenges-of-mitral-valve-repair-in-females-diagnosis-pathology-and-intervention
#50
JOURNAL ARTICLE
Mimi Xiaoming Deng, Batol Barodi, Malak Elbatarny, Terrence M Yau
PURPOSE OF REVIEW: Disparities in mitral valve (MV) repair outcomes exist between men and women. This review highlights sex-specific differences in MV disease aetiology, diagnosis, as well as timing and type of intervention. RECENT FINDINGS: Females present with more complicated disease: anterior or bileaflet prolapse, leaflet dysplasia/thickening, mitral annular calcification, and mixed mitral lesions. The absence of indexed echocardiographic mitral regurgitation (MR) severity parameters contributes to delayed intervention in women, resulting in more severe symptom burden at time of surgery...
December 7, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/38116841/which-lesions-are-not-amenable-to-tricuspid-clipping
#51
JOURNAL ARTICLE
Shahrukh N Bakar, Neil P Fam
PURPOSE OF REVIEW: Tricuspid transcatheter edge-to-edge repair (T-TEER) has emerged as a well tolerated and effective therapeutic option for many patients with symptomatic severe tricuspid regurgitation at prohibitive surgical risk. However, there remain several important limitations to clip-based technology in the context of other rapidly emerging percutaneous treatment options for tricuspid regurgitation. RECENT FINDINGS: Tricuspid lesions pose unique challenges to treatment with the current toolbox of transcatheter clip-based technologies...
November 30, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/37934698/low-density-lipoprotein-cholesterol-non-high-density-lipoprotein-cholesterol-and-apolipoprotein-b-for-cardiovascular-care
#52
JOURNAL ARTICLE
Selin Bilgic, Allan D Sniderman
PURPOSE OF REVIEW: Some experts and consensus groups continue to argue that apolipoprotein B (apoB) should not be introduced broadly into clinical care. But, too often, the present approach to clinical care is not succeeding. An important reason for this failure, we believe, is that the conventional approach limits what the expert clinician can accomplish and is too complex, confusing, and contradictory for primary care physicians to apply effectively in their practise. RECENT FINDINGS: There are four major reasons that apoB should be measured routinely in clinical care...
November 7, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/37792556/glucagon-like-peptide-1-glucose-dependent-insulinotropic-polypeptide-receptor-co-agonists-for-cardioprotection-type-2-diabetes-and-obesity-a-review-of-mechanisms-and-clinical-data
#53
REVIEW
Ronald M Goldenberg, Hwee Teoh, Subodh Verma
PURPOSE OF REVIEW: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are approved for the management of type 2 diabetes (T2D) and obesity, and some are recommended for cardiorenal risk reduction in T2D. To enhance the benefits with GLP-RA mono-agonist therapy, GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor co-agonists are in development to capitalize on the synergism of GLP-1 and GIP agonism. We review the mechanisms of action and clinical data for GLP-1/GIP receptor co-agonists in T2D and obesity and their potential role in cardiovascular protection...
November 1, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/37792555/introduction-to-the-coronary-artery-surgery-section
#54
JOURNAL ARTICLE
Marc Ruel, Robert Roberts
No abstract text is available yet for this article.
November 1, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/37792554/editorial-introductions
#55
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 1, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/37767898/the-plaque-hypothesis-understanding-mechanisms-of-plaque-progression-and-destabilization-and-implications-for-clinical-management
#56
REVIEW
Mona E Ahmed, Diaa Hakim, Peter H Stone
PURPOSE OF REVIEW: Major adverse cardiac events (MACE) typically arise from nonflow-limiting coronary artery disease and not from flow-limiting obstructions that cause ischemia. This review elaborates the current understanding of the mechanism(s) for plaque development, progression, and destabilization and how identification of these high-risk features can optimally inform clinical management. RECENT FINDINGS: Advanced invasive and noninvasive coronary imaging and computational postprocessing enhance an understanding of pathobiologic/pathophysiologic features of coronary artery plaques prone to destabilization and MACE...
November 1, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/37751394/antiplatelet-therapy-around-cabg-the-latest-evidence
#57
JOURNAL ARTICLE
Sigrid Sandner, Björn Redfors, Mario Gaudino
PURPOSE OF REVIEW: The optimal antiplatelet strategy in patients after coronary artery bypass graft (CABG) surgery is unclear. We review the evidence on the efficacy and safety of DAPT after CABG and discuss potential novel antiplatelet strategies that reduce the risk of bleeding without loss of efficacy. RECENT FINDINGS: Adding the potent P2Y12 inhibitor ticagrelor to aspirin for 1 year after CABG is associated with a reduction in the risk of vein graft failure, at the expense of an increased risk of clinically important bleeding...
November 1, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/37668170/preoperative-optimization-and-rapid-discharge-after-coronary-artery-bypass-grafting
#58
REVIEW
Menaka Ponnambalam, Rozen M Alex
PURPOSE OF REVIEW: This review discusses current guidelines and evidence-based care for the preoperative optimization of patients who are undergoing coronary artery bypass grafting (CABG) and for enabling rapid discharge after surgery. RECENT FINDINGS: Since the Enhanced Recovery After Cardiac Surgery Society (ERAS Cardiac) issued guidelines for perioperative care, in 2019, there has been a significant body of research that has added to and provided further guidance regarding preoperative optimization and accelerated recovery after CABG...
November 1, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/37522805/antithrombotic-treatment-following-percutaneous-coronary-intervention-in-patients-with-high-bleeding-risk
#59
REVIEW
Zaid I Almarzooq, Nora M Al-Roub, Scott Kinlay
PURPOSE OF REVIEW: Review the clinical outcomes of different antithrombotic strategies in patients with high bleeding risk (HBR) after percutaneous coronary intervention (PCI). RECENT FINDINGS: Patients with HBR after PCI include those with advanced age (e.g. >75 years of age), a prior history of major bleeding, anemia, chronic kidney disease, and those with indications for long-term anticoagulation. Strategies that successfully decrease bleeding risk in this population include shorter durations of dual antiplatelet therapy (DAPT; of 1-3 months) followed by single antiplatelet therapy with aspirin or a P2Y 12 inhibitor, or de-escalating from a more potent P2Y 12 inhibitor (prasugrel or ticagrelor) to less potent antiplatelet regimens (aspirin with clopidogrel or half-dose ticagrelor or half-dose prasugrel)...
November 1, 2023: Current Opinion in Cardiology
https://read.qxmd.com/read/37874028/left-atrial-appendage-closure-the-journey-today-and-tomorrow
#60
JOURNAL ARTICLE
Marvin Louis Roy Lu, David Bowers De Lurgio
PURPOSE OF REVIEW: This review aims to discuss the rationale behind the development of percutaneous LAAC devices as a treatment option for atrial fibrillation patients ineligible for long-term anticoagulation. The evolution of LAAC, from early experiences and challenges to risk mitigation and improved devices and techniques, will be examined. Furthermore, the review will explore our current understanding of the potential and limitations of LAAC in stroke prevention. RECENT FINDINGS: Multiple trials confirm LAAC device safety and efficacy for stroke prevention, but peri-device leak and thrombus remain concerns postimplantation...
October 23, 2023: Current Opinion in Cardiology
journal
journal
29307
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.